Abstract Details

Title Severe Exacerbation of Myasthenia Gravis Associated with Checkpoint Inhibitor Immunotherapy

Topic Neuromuscular and Clinical Neurophysiology (EMG)

Presentation(s) P6 - (-)

Poster/Presentation
Number 450

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Dana S. Cooper, MD (Cedars-Sinai Medical Center) PRESENTER	No disclosure on file
Matthew N. Meriggioli, MD, FAAN (Novartis Biomedical Research)	Dr. Meriggioli has received personal compensation for serving as an employee of Novartis Gene Therapies. Dr. Meriggioli has received stock or an ownership interest from Novartis.
	No disclosure on file
Rabia Malik, MD (Rush University Medical Center)	Dr. Malik has nothing to disclose.

��ɫ����